ACADIA Pharmaceuticals Inc (ACAD)
14.62
-0.19
(-1.28%)
USD |
NASDAQ |
Nov 04, 16:00
14.62
0.00 (0.00%)
After-Hours: 07:38
ACADIA Pharmaceuticals Total Assets (Quarterly): 914.10M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 914.10M |
| March 31, 2024 | 855.10M |
| December 31, 2023 | 748.96M |
| September 30, 2023 | 632.54M |
| June 30, 2023 | 642.77M |
| March 31, 2023 | 655.30M |
| December 31, 2022 | 587.81M |
| September 30, 2022 | 602.49M |
| June 30, 2022 | 612.77M |
| March 31, 2022 | 624.25M |
| December 31, 2021 | 700.12M |
| September 30, 2021 | 717.67M |
| June 30, 2021 | 724.43M |
| March 31, 2021 | 755.17M |
| December 31, 2020 | 782.62M |
| September 30, 2020 | 795.66M |
| June 30, 2020 | 759.65M |
| March 31, 2020 | 747.45M |
| December 31, 2019 | 783.18M |
| September 30, 2019 | 765.59M |
| June 30, 2019 | 460.88M |
| March 31, 2019 | 501.10M |
| December 31, 2018 | 540.20M |
| September 30, 2018 | 266.46M |
| June 30, 2018 | 314.96M |
| Date | Value |
|---|---|
| March 31, 2018 | 351.04M |
| December 31, 2017 | 384.51M |
| September 30, 2017 | 413.71M |
| June 30, 2017 | 456.32M |
| March 31, 2017 | 503.01M |
| December 31, 2016 | 561.15M |
| September 30, 2016 | 617.38M |
| June 30, 2016 | 438.03M |
| March 31, 2016 | 466.59M |
| December 31, 2015 | 221.90M |
| September 30, 2015 | 245.32M |
| June 30, 2015 | 275.54M |
| March 31, 2015 | 301.96M |
| December 31, 2014 | 325.46M |
| September 30, 2014 | 341.76M |
| June 30, 2014 | 359.46M |
| March 31, 2014 | 373.51M |
| December 31, 2013 | 189.12M |
| September 30, 2013 | 199.28M |
| June 30, 2013 | 206.91M |
| March 31, 2013 | 103.02M |
| December 31, 2012 | 108.59M |
| September 30, 2012 | 23.75M |
| June 30, 2012 | 21.87M |
| March 31, 2012 | 26.52M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
587.81M
Minimum
Dec 2022
914.10M
Maximum
Jun 2024
718.00M
Average
724.43M
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| Biogen Inc | 28.31B |
| Madrigal Pharmaceuticals Inc | 1.073B |
| Supernus Pharmaceuticals Inc | 1.316B |
| Geovax Labs Inc | 4.095M |
| Myomo Inc | 16.19M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 397.40M |
| Shareholders Equity (Quarterly) | 516.70M |
| Current Ratio | 2.158 |